675 WEST KENDALL STREET, CAMBRIDGE, MA
Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress
Material disclosure
Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
Annual Report to Security Holders
CEO Appointment - Yvonne Greenstreet Named Chief Executive Officer
Financial Results, Press Release
Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence